✦ LIBER ✦

Effect of adjuvant endocrine therapy on hormonal levels in premenopausal women with breast cancer: the ProBONE II study

✍ Scribed by Hadji, Peyman; Kauka, Annette; Ziller, May; Birkholz, Katrin; Baier, Monika; Muth, Mathias; Kann, Peter

Book ID: 121533440
Publisher: Springer US
Year: 2014
Tongue: English
Weight: 405 KB
Volume: 144
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-014-2860-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of zoledronic acid on bone miner

Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR+breast cancer: the ProBONE II study

✍ Hadji, P.; Kauka, A.; Ziller, M.; Birkholz, K.; Baier, M.; Muth, M.; Bauer, M. 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 350 KB

Cost-Effectiveness of Zoledronic Acid Pl

Cost-Effectiveness of Zoledronic Acid Plus Endocrine Therapy in Premenopausal Women With Hormone-Responsive Early Breast Cancer

✍ Thomas E. Delea; Charu Taneja; Oleg Sofrygin; Satyin Kaura; Michael Gnant 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 644 KB

Postmastectomy radiotherapy in premenopa

Postmastectomy radiotherapy in premenopausal Vietnamese and Chinese women with breast cancer treated in an adjuvant hormonal therapy study

✍ Richard R Love; Nguyen Ba Duc; Nguyen Cong Binh; Peter A Mahler; Bruce R Thomads 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Aromatase inhibitors: effective endocrin

Aromatase inhibitors: effective endocrine therapy in the early adjuvant setting for postmenopausal women with hormone-responsive breast cancer

✍ Louis Mauriac 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 259 KB

Effect of chemotherapy with or without b

Effect of chemotherapy with or without buserelin on serum hormone levels in premenopausal women with breast cancer

✍ Falkson, Carla I; Falkson, HendréC; Falkson, Geoffrey 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 524 KB

Combined endocrine effects of LHRH agoni

Combined endocrine effects of LHRH agonist (Zoladex®) and tamoxifen (Nolvadex®) therapy in premenopausal women with breast cancer

✍ Mr J. F. R. Robertson; K. J. Walker; R. I. Nicholson; R. W. Blamey 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 2 views

Abstract In premenopausal women with breast cancer, the use of the luteinizing hormone releasing hormone agonist, goserelin, results in the production of serum levels of oestradiol equivalent to those after surgical oöphorectomy or in postmenopausal women. The standard first line hormonal treatment